Opioidisõltuvuse asendusravi teenuse osutamiseks teenuseosutajate leidmine

This compliance document only confirms that bidders must declare (mandatory) they will not use Russian-linked subcontractors for >10 % of the contract value and, if bidding as a consortium, must upload a joint-bid authorisation; no clinical, staffing or financial qualification criteria are stated here.

This document is merely a blank “business secrecy” form that bidders must sign to declare which parts of their offer (other than price) they wish to keep confidential; it contains no tender requirements, qualifications or evaluation criteria and therefore gives no basis for deciding whether to bid.

This CV template (non-mandatory) is used to demonstrate that the proposed nurse has relevant opioid-dependence substitution therapy experience, education and recent training, so bidders should assign staff with addiction-treatment credentials and at least 5 years’ recent field experience to strengthen their offer.

This single procurement-document only asks bidders to submit a CV (in the prescribed template) for each proposed “other specialist” who will deliver Estonia’s opioid-substitution service; no mandatory qualifications, experience thresholds or evaluation scoring are stated, so any provider already licensed to dispense opioid-substitution therapy should bid if it can field staff with relevant addiction-treatment education and recent practical experience.

Tervise Arengu Instituut otsib opioidisõltuvuse asendusravi hankele psühhiaatrit, kelle CV (kohustuslik) peab näitama erialast haridust, viimase 5 aasta täiendkoolitusi ja töökogemust seotud valdkonnas – ettevõtted peaksid hindama, kas neil on vajalik spetsialist ja tema CV vastab vorminõuetele.

This document is only the blank CV template that the Estonian Health Development Institute (Tervise Arengu Instituut) will use to evaluate whether each proposed team member meets the (undisclosed) mandatory professional, educational and recent training requirements for delivering opioid-substitution therapy services.

This document is a mandatory social-worker CV template (fields: 5-year training & addiction-care experience, relevant degree) that bidders must complete to qualify for the Estonian Health Institute’s opioid-substitution therapy tender.

Two-lot public contract (Harjumaal, Tallinn) for opioid-substitution therapy services—mandatory submission of a site-specific service-management & risk-mitigation plan aligned with the national clinical protocol (50 % of score) plus a VAT-excluded lump-sum price bid (50 %), so only licensed addiction-treatment providers able to document clinical capacity and undercut on cost should consider bidding.

This is only the ESPD template (not the actual tender conditions), so it merely shows that to bid on the Estonian Health Institute’s procurement for opioid-substitution treatment providers you will later have to fill in company data and declare that you meet whatever mandatory exclusion/qualification criteria the buyer sets, but the document itself gives no detail on required licences, staff, turnover or how offers will be evaluated.

This document contains only Tervise Arengu Instituut’s general terms of service contracts (valid from 16.06.2025) and gives no mandatory service specifications, qualification criteria or evaluation rules for the opioid-substitution tender—bidders must wait for the full tender dossier to decide whether to bid.

This document is only a blank 2026 financial-report template for recording monthly staff costs (including 33.8 % payroll taxes) for the opioid-substitution therapy contract and therefore contains no mandatory requirements, qualifications or evaluation criteria for bidders.

This document is merely a blank individual-treatment-plan form (to be signed by patient and clinician) that accompanies the clinical protocol for opioid-substitution therapy; it contains no business requirements, qualification criteria, evaluation rules or mandatory obligations for potential bidders, so it gives no basis for deciding whether to pursue the tender.

This clinical protocol addendum (mandatory) warns service providers that opioid-substitution patients must be protected from potentially addictive prescription drugs—especially benzodiazepines, Z-drugs, pregabalin and others—so bidders must demonstrate robust physician training, strict controlled-drug prescribing policies and real-time prescription-monitoring systems to avoid fatal poly-drug overdoses.

This emergency-response annex (mandatory for all bidders) requires opioid-substitution providers to prove they can keep service running 24/7 during any crisis—via home delivery of medication, paper back-up records, mechanical dispensers, up-to-date patient contact lists and written evacuation/delivery protocols—so only tenderers that already have crisis staff-safety plans, logistics partners for drug transport and both digital & manual dispensing equipment should consider bidding.

This document is a mandatory crisis-management annex that requires all bidders to prove they can keep opioid-substitution services running during emergencies (pandemics, cyber-attacks, transport outages, etc.) by having written safety protocols, backup medication-delivery plans (home visits, trusted proxies, paper records), redundant communication channels and either manual or mechanical drug-dispensing equipment if digital systems fail.

This document is merely a blank crisis-period consent form that patients and clinics must complete to authorize opioid-substitution treatment during emergencies; it contains no tender requirements, qualification criteria, or bidding instructions.

This clinical protocol template (Lisa 3.1) is a mandatory form that service providers must use to document each opioid-substitution patient’s treatment plan, periodic outcomes and social/work status, implying bidders need proven capability to deliver structured, long-term medical and psychosocial follow-up compliant with Estonian health-service standards.

This document is merely a blank 2026 monthly activity report template (patient counts, treatment days, program drop-outs) that the Estonian Health Development Institute will require the winning opioid-substitution service provider to complete—no selection criteria, qualifications or mandatory requirements are stated.

Tervise Arengu Instituut otsib § 126/127 erimenetlusega kuni 1,62 M€ eelarvega partnerit, kes suudab 2-osaliselt (Tallinn 430 k€, Tartu 396,5 k€) pakkuda opioidisõltuvuse asendusravi (ravim + psühholoogiline ja sotsiaalne tugi) integreeritud meeskonnaga (tervishoid + sotsiaalvaldkond) – kvalifikatsiooninõudeid ja hindamiskriteeriume dokumendis veel pole, kuid teenus on suunatud riskirühmale ja kuulub sotsiaal-tervishoiuteenuste kategooriasse.

This is a draft service contract (not the tender notice itself) under which the Estonian Health Development Institute will buy 2026-only opioid-substitution therapy that must be provided free-of-charge to patients, paid from a fixed state budget that can be cut proportionally if funding falls, so bidders need to be ready to treat the forecast monthly patient volume (±5 %) at the lump-sum price they offered and to start service on 1 Jan 2026 if the draft is signed.

This is only a blank joint-bid power-of-attorney template (not the actual tender rules) that two or more Estonian companies must fill in and digitally sign if they intend to submit a combined offer for the Health Board’s procurement of opioid-substitution treatment services.

This is only a blank power-of-attorney template; it contains no mandatory service requirements, qualification thresholds or evaluation criteria—merely a form that bidders may (optionally) complete to authorise a representative to sign their offer for the Estonian Health Institute’s opioid-substitution therapy procurement.